Press release
NEUWAY Pharma Extends First Round Financing to € 5.85 Million
Bonn, October 22, 2015 - NEUWAY Pharma announced today the successful closing of a € 3.15 Mio Series A Extension financing round to a total of € 5.85 Million. The lead investor Wellington Partners provided € 2.0 Million of the acquired funds. Life Science Inkubator, Kreditanstalt für Wiederaufbau (KfW) and several private shareholders also participated in the financing round.Besides the development of the proprietary CNS drug delivery platform, the financial resources allow NEUWAY the production of clinical trial material according to GMP. “I am pleased about the great confidence the investors and shareholders have in our company. Continued funding will accelerate the development of our technology and we will soon be able to start testing with GMP material”, says Dr. Heiko Manninga, co-founder and Managing Director of NEUWAY.
“Solid financial backing will enable NEUWAY to transform itself from a research company to a development company”, comments Dr. Rainer Strohmenger, General Partner at Wellington Partners, “ We believe in broad applicability of the CNS drug delivery platform of NEUWAY and we will do everything to support the company in their further development.”
NEUWAY Pharma GmbH, Bonn, Germany, is focusing on the preclinical and clinical development of innovative therapeutics for treatment of orphan brain diseases based on its proprietary CNS drug delivery platform. The company also intends to partner its drug delivery technology for other CNS indications.
NEUWAY had been founded in April 2014 as the first spin-off from Life Science Inkubator GmbH, Bonn, Germany, where it had been incubated for the last 4 years and supported with approx. € 2.3 million in research funding by the Federal Ministry of Education and Research. The company closed a series A financing round in May 2014 with a volume of € 2.7 million provided by a syndicate led by Wellington Partners.
NEUWAY Pharma GmbH
Ludwig-Erhard-Allee 2
53175 Bonn, Germany
+49-228-5227980
Press Contact Christine Kuhn
kuhn@neuway.de
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release NEUWAY Pharma Extends First Round Financing to € 5.85 Million here
News-ID: 318871 • Views: …
More Releases from NEUWAY Pharma GmbH
NEUWAY Pharma GmbH Names Dr. Oliver Ernst Managing Director, Chief Operating Off …
Bonn, February 25, 2019 - NEUWAY Pharma announced today the appointment of Dr. Oliver Ernst as Managing Director and Chief Operating Officer. Dr. Ernst brings many years of experience in the management of intellectual property rights (IP) in the area of software-based medical technology, pharmaceuticals, and biotechnology, as well as the development of a sustainable, business-related IP strategy. Dr. Ernst previously worked in one of…
NEUWAY Receives €2.95 Million BMBF Grant for Advancing CNS Drug Delivery Platf …
• Grant secures execution of work packages necessary to further validate NEUWAY`s central nervous system (CNS) Drug Delivery Platform for a diverse set of active pharmaceutical substances
• Grant also allows NEUWAY to set-up good manufacturing practice (GMP) production and preparing clinical Phase I study
Bonn, June 07, 2016 - NEUWAY Pharma GmbH, a biopharmaceutical company developing drugs for the treatment of severe orphan CNS diseases, announced today the successful acquisition of non-dilutive funding…
NEUWAY Pharma GmbH appoints Dr. Rudi Scherhag as Managing Director
Bonn, August 18, 2015 - NEUWAY Pharma announced today the appointment of Dr. Rudi Scherhag as Chief Operating Officer and Managing Director. Dr. Scherhag has extensive experience in managing various development projects from pre-clinical to registration in the pharmaceutical and biotech industry.
As planned, Dr. Scherhag will take over the managing director position from Dr. Stephan Rapp, who will focus on new projects and act as consultant and shareholder of NEUWAY.
Dr.…
More Releases for Bonn
Digestive Biscuits Market Is Booming So Rapidly | Bonn Nutrients, Tesco, Abisco
The Global Digestive Biscuits Market Size is is forecast to register an annual growth rate (CAGR) of 5.7%.
The latest study released on the Global Digestive Biscuits Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Digestive Biscuits market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed…
BONN STEICHEN & PARTNERS NEW RESPONSIVE WEBSITE UNVEILS
Bonn Steichen & Partners is the first law firm in Luxembourg to launch its redesigned content driven website on a fully responsive solution: bsp.lu
By using Responsive Web Design, Bonn Steichen & Partners law firm has fallen within the latest technical requirements with respect to websites. Optimised for use on every device, the new website offers viewers an enhanced and consistent user experience regardless of whether they use a…
FIRST ROUND OF PROMOTION AT BONN STEICHEN & PARTNERS
Leading independent Luxembourg law firm, Bonn Steichen & Partners, continues its growth with the appointment of former counsel Linda HARROCH to new Partner and the promotion of two Counsels and one Senior Associate.
With more than twelve years' experience in private equity and corporate law, Linda Harroch has been promoted to Partner at BSP. She advises major international companies, PE firms and real estate funds on fund structuring and formation…
New opening of Beta Sport & Reha at Beta Klinik in Bonn, Germany
Bonn, Germany. Physical fitness does not only enhance the physical well-being but also the mental performance and the quality of life. Improve you quality of life through training and therapy at Beta Sport & Reha, new opening on 5th November 2010 from 3 to 6 pm. At the new opening, you can enjoy our program (live presentation of our training machines and physical performance diagnostics) and benefit from our exclusive…
PSI Awarded Contract by Cologne-Bonn Airport and Lufthansa
Berlin, 16 June 2010 – PSI subsidiary PSI Logistics GmbH has been awarded by the Flughafen Köln/Bonn GmbH and Lufthansa AG with the delivery of the standard product PSIairport/BRS for the control and documentation of the luggage handling.
Along with Berlin-Tegel, Hamburg and Nuremberg, the Cologne-Bonn Airport is now also using PSI’s Baggage Reconciliation System. The airport will continue to use the existing infrastructure and the data from the luggage conveyor…
TÜV certifies Beta Klinik in Bonn, Germany
Bonn, Germany. Beta Klinik in Bonn, Germany, provides TÜV-certified quality. On 14 April, CEO Feridoon Sergizzarea and Kurt Lindenblatt of TÜV Intercert presented CEO Prof. Dr. Jürgen Reul, Deputy CEO Dr. Axel Jung and Quality Management Agent Brigitta May of Beta Klinik with the TÜV certificate. Beta Klinik now is certified in compliance with the internationally recognized quality standard DIN ISO 9001.
The DIN ISO 9001 certificate is given to…
